Old Pal Taps Nabis for Exclusive Distribution Partnership to Bolster Footprint Across California’s Cannabis Market

SAN FRANCISCO–(BUSINESS WIRE)–Nabis, the leading licensed cannabis wholesale platform in the world’s largest legal cannabis market, today announces an exclusive distribution partnership with multi-state operating flower brand Old Pal to expand its reach in California, and bring ethically, sustainably sourced cannabis to consumers across the state. Retailers with access to Nabis’ Marketplace are now able to order and receive Old Pal’s products, such as its Infused Blunts and Ready to Roll kits

Global Blockchain Technology Market to 2028: Players Include Coinbase, Coinfirm, ConsenSys Systems, Dell Technologies and Deloitte Touche Tohmatsu – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Blockchain Technology Market by Use Case, Business Model, Solutions, Services and Applications in Industry Verticals 2023 – 2028” report has been added to ResearchAndMarkets.com’s offering. This report examines the technology, leading companies, and solutions in the evolving blockchain ecosystem. The report evaluates current and anticipated use cases for blockchain and assesses the market potential globally, regionally, and segmented by deployment type and industry

HEXO Ranks on The Globe and Mail’s Fourth-Annual Women Lead Here Benchmark of Executive Gender Diversity

GATINEAU, Québec–(BUSINESS WIRE)–HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the “Company”), is pleased to announce it has been included on The Globe and Mail’s 2023 Report on Business magazine’s Women Lead Here list. This annual editorial benchmark identifies top-notch Canadian businesses with the highest executive gender diversity. “We are honoured that The Globe and Mail has recognized our continued efforts towards gender diversity and parity,” says Mona Matta, Vice-President, People a

Putnam Investments Announces Distribution Rates for Class A Open-End Funds

BOSTON–(BUSINESS WIRE)–The Trustees of The Putnam Funds have declared the following distributions. FUND NAME AND DISTRIBUTIONS RECORD/ EX DATE PAYMENT DATE       Putnam Dynamic Asset Allocation Conservative Fund– Class A Shares (PACAX) $0.0160 per share investment income 4/18/23 4/20/23       Putnam Diversified Income Trust – Class A Shares (PDINX) $0.0290 per share investment income 4/18/23 4/20/23       Putnam Core Bond Fund – Class A Shares (PTRNX) $0.0330 per share investment income 4/18/

Applied UV Declares Monthly Preferred Stock Dividend

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (Nasdaq CM: AUVI ) (“Applied UV” or the “Company”), a leading provider of best in class suite of proprietary, patented, scientific and clinically proven, surface and air disinfection technologies (fixed, mobile and HVAC), LED lighting products and hotel furnishings used by clients globally, announces today its Board of Directors has authorized the cash dividend to holders of Applied UV’s 10.5% Series A Cumulative Perpetual Preferred Stock. H

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Rite Aid Corporation (RAD) Investors of Class Action and to Actively Participate

NEW YORK–(BUSINESS WIRE)—- $RAD #classaction–Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Rite Aid Corporation (NYSE:RAD) (“Rite Aid” or the “Company”) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Rite Aid securities between April 26, 2018 and March 13, 2023, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: w

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced that it has entered into an agreement with Avance Clinical, an Australia-based contract research organization (CRO) with US operations, for its planned Phase 1 clinical trial of EB-373, the company’s lead candidate targe

The House of Cannabis to Debut in SoHo on April 7th, Ticket Sales Live

NEW YORK–(BUSINESS WIRE)–Today, The House of Cannabis (THCNYC) announces tickets are on sale for an April 7th grand opening. The House of Cannabis is the first-ever, permanent home celebrating “high culture” and its impact on music, art, fashion, social reform and cultivation. Ten mind-bending, immersive experiences created by artists and filmmakers, transport guests through the many dimensions of cannabis culture. Tickets are available at www.thcnyc.com. “This is the first-ever physical home